Haemolytic anaemia in malignant lymphoreticuloendothelial diseases.
D000328:Adult; D000743:Anemia, Hemolytic / Q000209:etiology*; D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology*; D001323:Autoantibodies / Q000032:analysis; D001856:Bone Marrow Examination; D002470:Cell Survival; D002699:Chlorambucil / Q000627:therapeutic use; D002860:Chromium Radioisotopes; D003298:Coombs Test; D003520:Cyclophosphamide / Q000627:therapeutic use; D004912:Erythrocytes; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007945:Leukemia, Lymphoid / Q000150:complications*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D001323:Autoantibodies; D002860:Chromium Radioisotopes; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D002699:Chlorambucil; D014747:Vinblastine; D003520:Cyclophosphamide; D011239:Prednisolone